In contrast, in other tumors, including hepatocellular carcinoma and ovarian cancer, the more general genomic alteration of FUBP1 is excessive expression, which is often inversely correlated with overall survival [2, 27]. This evidence concerns the gene FUBP1 and ovarian cancer.